Page 1 | Search Results | Clinical Cancer Research | American Association for Cancer Research

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Response-Adaptive Surgical Timing in neoadjuvant immunotherapy demonstrates enhanced pathologic treatment response in Head and Neck Squamous Cell Carcinoma

Clin Cancer Res (2024)

https://doi.org/10.1158/1078-0432.CCR-24-0037

Published: 25 November 2024

View article titled, Response-Adaptive Surgical Timing in neoadjuvant immunotherapy demonstrates enhanced pathologic treatment response in Head and Neck Squamous Cell Carcinoma

Includes: Supplementary data

Journal Articles

Multi-scale Pan-cancer Integrative Analyses Identify the STAT3-VSIR Axis as a Key Immunosuppressive Mechanism in Head and Neck Cancer

Ramachandra Katabathula, Peronne Joseph, Salendra Singh, Songzhu Zhao, Bhavna Kumar, Patricia Gaule, Quintin Pan, Matthew Old, David P. Tuck, Vinay Varadan

Clin Cancer Res (2022) 28 (5): 984–992.

https://doi.org/10.1158/1078-0432.CCR-21-1978

Published: 03 March 2022

View article titled, Multi-scale Pan-cancer Integrative Analyses Identify the STAT3-VSIR Axis as a Key Immunosuppressive Mechanism in Head and Neck Cancer

Includes: Supplementary data

Journal Articles

Nitric Oxide Production by Myeloid-Derived Suppressor Cells Plays a Role in Impairing Fc Receptor–Mediated Natural Killer Cell Function

Clin Cancer Res (2018) 24 (8): 1891–1904.

https://doi.org/10.1158/1078-0432.CCR-17-0691

Published: 12 April 2018

View article titled, Nitric Oxide Production by Myeloid-Derived Suppressor Cells Plays a Role in Impairing Fc Receptor–Mediated Natural Killer Cell Function

Includes: Supplementary data

Journal Articles

BAI1 Orchestrates Macrophage Inflammatory Response to HSV Infection—Implications for Oncolytic Viral Therapy

Clin Cancer Res (2017) 23 (7): 1809–1819.

https://doi.org/10.1158/1078-0432.CCR-16-1818

Published: 02 April 2017

View article titled, BAI1 Orchestrates Macrophage Inflammatory Response to HSV Infection—Implications for Oncolytic Viral Therapy

Includes: Supplementary data

Journal Articles

Bortezomib Treatment Sensitizes Oncolytic HSV-1–Treated Tumors to NK Cell Immunotherapy

Ji Young Yoo, Alena Cristina Jaime-Ramirez, Chelsea Bolyard, Hongsheng Dai, Tejaswini Nallanagulagari, Jeffrey Wojton, Brian S. Hurwitz, Theresa Relation, Tae Jin Lee, Michael T. Lotze, Jun-Ge Yu, Jianying Zhang, Carlo M. Croce, Jianhua Yu, Michael A. Caligiuri, Matthew Old, Balveen Kaur

Clin Cancer Res (2016) 22 (21): 5265–5276.

https://doi.org/10.1158/1078-0432.CCR-16-1003

Published: 31 October 2016

View article titled, Bortezomib Treatment Sensitizes Oncolytic HSV-1–Treated Tumors to NK Cell Immunotherapy

Includes: Supplementary data

Journal Articles

Bortezomib-Induced Unfolded Protein Response Increases Oncolytic HSV-1 Replication Resulting in Synergistic Antitumor Effects

Ji Young Yoo, Brian S. Hurwitz, Chelsea Bolyard, Jun-Ge Yu, Jianying Zhang, Karuppaiyah Selvendiran, Kellie S. Rath, Shun He, Zachary Bailey, David Eaves, Timothy P. Cripe, Deborah S. Parris, Michael A. Caligiuri, Jianhua Yu, Matthew Old, Balveen Kaur

Clin Cancer Res (2014) 20 (14): 3787–3798.

https://doi.org/10.1158/1078-0432.CCR-14-0553

Published: 14 July 2014

View article titled, Bortezomib-Induced Unfolded Protein Response Increases Oncolytic HSV-1 Replication Resulting in Synergistic Antitumor Effects

Includes: Supplementary data

Journal Articles

Copper Chelation Enhances Antitumor Efficacy and Systemic Delivery of Oncolytic HSV

Ji Young Yoo, Jason Pradarelli, Amy Haseley, Jeffrey Wojton, Azeem Kaka, Anna Bratasz, Christopher A. Alvarez-Breckenridge, Jun-Ge Yu, Kimerly Powell, Andrew P. Mazar, Theodoros N. Teknos, E. Antonio Chiocca, Joseph C. Glorioso, Matthew Old, Balveen Kaur

Clin Cancer Res (2012) 18 (18): 4931–4941.

https://doi.org/10.1158/1078-0432.CCR-12-0697

Published: 16 September 2012

View article titled, Copper Chelation Enhances Antitumor Efficacy and Systemic Delivery of Oncolytic HSV

Includes: Supplementary data

NARROW

Response-Adaptive Surgical Timing in neoadjuvant immunotherapy demonstrates enhanced pathologic treatment response in Head and Neck Squamous Cell Carcinoma

Multi-scale Pan-cancer Integrative Analyses Identify the STAT3-VSIR Axis as a Key Immunosuppressive Mechanism in Head and Neck Cancer

Nitric Oxide Production by Myeloid-Derived Suppressor Cells Plays a Role in Impairing Fc Receptor–Mediated Natural Killer Cell Function

BAI1 Orchestrates Macrophage Inflammatory Response to HSV Infection—Implications for Oncolytic Viral Therapy

Bortezomib Treatment Sensitizes Oncolytic HSV-1–Treated Tumors to NK Cell Immunotherapy

Bortezomib-Induced Unfolded Protein Response Increases Oncolytic HSV-1 Replication Resulting in Synergistic Antitumor Effects

Copper Chelation Enhances Antitumor Efficacy and Systemic Delivery of Oncolytic HSV

Email alerts

AACR Journals

Response-Adaptive Surgical Timing in neoadjuvant immunotherapy demonstrates enhanced pathologic treatment response in Head and Neck Squamous Cell Carcinoma

Multi-scale Pan-cancer Integrative Analyses Identify the STAT3-VSIR Axis as a Key Immunosuppressive Mechanism in Head and Neck Cancer

Nitric Oxide Production by Myeloid-Derived Suppressor Cells Plays a Role in Impairing Fc Receptor–Mediated Natural Killer Cell Function

BAI1 Orchestrates Macrophage Inflammatory Response to HSV Infection—Implications for Oncolytic Viral Therapy

Bortezomib Treatment Sensitizes Oncolytic HSV-1–Treated Tumors to NK Cell Immunotherapy

Bortezomib-Induced Unfolded Protein Response Increases Oncolytic HSV-1 Replication Resulting in Synergistic Antitumor Effects

Copper Chelation Enhances Antitumor Efficacy and Systemic Delivery of Oncolytic HSV

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only